Abstract
We hereby describe the satisfactory evolution of rituximab treatment in two patients with Wegener's granulomatosis (WG). Rituximab was indicated for refractoriness to standard treatment in one case and life-threatening myelotoxicity due to alkylating agents in the other. A brief review of previous experience with the use of rituximab in the treatment of WG is presented. © Oristrell et al.; Licensee Bentham Open.
Original language | English |
---|---|
Pages (from-to) | 94-99 |
Journal | Open Respiratory Medicine Journal |
Volume | 3 |
DOIs | |
Publication status | Published - 1 Dec 2009 |
Keywords
- Rescue treatment
- Rituximab
- Wegener's granulomatosis